Autocrine growth function of interleukin-1-like molecules secreted by neoplastic human B cells.

[1]  S. Venuta,et al.  Autocrine growth function of human interleukin 1 molecules on ROHA-9, an EBV-transformed human B cell line. , 1987, Journal of immunology.

[2]  G. Mundy,et al.  Tumor products and the hypercalcemia of malignancy. , 1985, The Journal of clinical investigation.

[3]  C. March,et al.  Detection and characterization of high affinity plasma membrane receptors for human interleukin 1 , 1985, The Journal of experimental medicine.

[4]  K. Matsushima,et al.  Production of interleukin 1 activity by normal human peripheral blood B lymphocytes. , 1985, Journal of immunology.

[5]  C. March,et al.  Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs , 1985, Nature.

[6]  R. Eisenman,et al.  c-myc oncogene protein synthesis is independent of the cell cycle in human and avian cells , 1985, Nature.

[7]  A. Fauci,et al.  Human B lymphoma cell line producing B cell growth factor. , 1985, The Journal of clinical investigation.

[8]  A. C. Webb,et al.  Nucleotide sequence of human monocyte interleukin 1 precursor cDNA. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[9]  P. Leder,et al.  Functional role for c-myc in mitogenic response to platelet-derived growth factor , 1984, Nature.

[10]  A. Muchmore,et al.  Accessory cell function of human B cells. I. Production of both interleukin 1-like activity and an interleukin 1 inhibitory factor by an EBV-transformed human B cell line , 1984, The Journal of experimental medicine.

[11]  M. Steinmetz,et al.  Interleukin-3 supports growth of mouse pre-B-cell clones in vitro , 1984, Nature.

[12]  P. Allavena,et al.  Human large granular lymphocytes are potent producers of interleukin-1 , 1984, Nature.

[13]  C. Heldin,et al.  Growth factors: Mechanism of action and relation to oncogenes , 1984, Cell.

[14]  P. Åman,et al.  Soluble factor requirements for the autostimulatory growth of B lymphoblasts immortalized by Epstein-Barr virus , 1984, The Journal of experimental medicine.

[15]  W. Paul,et al.  Role of interleukin 1 in anti-immunoglobulin-induced B cell proliferation , 1983, The Journal of experimental medicine.

[16]  R. Mertelsmann,et al.  Production and regulation of interleukin-2 in human lymphoblastic leukemias studied with T-cell monoclonal antibodies , 1983 .

[17]  I. Gery,et al.  Interleukin 1 is more than an interleukin. , 1982, Immunology today.

[18]  P. Marrack,et al.  B cell helper factors. I. Requirement for both interleukin 2 and another 40,000 mol wt factor , 1981, The Journal of experimental medicine.

[19]  G. Currie.  Promotion of fibrosarcoma cell growth by products of syngeneic host macrophages. , 1981, British Journal of Cancer.

[20]  M. Sporn,et al.  Autocrine secretion and malignant transformation of cells. , 1980, The New England journal of medicine.

[21]  I. Gery,et al.  POTENTIATION OF THE T-LYMPHOCYTE RESPONSE TO MITOGENS , 1972, The Journal of experimental medicine.

[22]  C. Janeway,et al.  Progress in immunology. Syndromes of diminished resistance to infection. , 1968, The Journal of pediatrics.

[23]  C. V. Oss,et al.  Progress in immunology V , 1985 .

[24]  A. Fauci,et al.  Development of a human T-T cell hybridoma secreting B cell growth factor , 1983, Journal of Experimental Medicine.

[25]  B. Ozanne,et al.  Transforming growth factor(s) production enables cells to grow in the absence of serum: an autocrine system. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[26]  R. Treisman,et al.  Transcription maps of polyoma virus-specific RNA: analysis by two-dimensional nuclease S1 gel mapping. , 1980, Methods in enzymology.